BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24844401)

  • 21. Genetic Loci associated with C-reactive protein levels and risk of coronary heart disease.
    Elliott P; Chambers JC; Zhang W; Clarke R; Hopewell JC; Peden JF; Erdmann J; Braund P; Engert JC; Bennett D; Coin L; Ashby D; Tzoulaki I; Brown IJ; Mt-Isa S; McCarthy MI; Peltonen L; Freimer NB; Farrall M; Ruokonen A; Hamsten A; Lim N; Froguel P; Waterworth DM; Vollenweider P; Waeber G; Jarvelin MR; Mooser V; Scott J; Hall AS; Schunkert H; Anand SS; Collins R; Samani NJ; Watkins H; Kooner JS
    JAMA; 2009 Jul; 302(1):37-48. PubMed ID: 19567438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survival.
    Penney KL; Li H; Mucci LA; Loda M; Sesso HD; Stampfer MJ; Ma J
    Prostate; 2013 May; 73(7):700-5. PubMed ID: 23129481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum C-reactive protein and risk of lung cancer: a case-control study.
    Xu M; Zhu M; Du Y; Yan B; Wang Q; Wang C; Zhao J
    Med Oncol; 2013 Mar; 30(1):319. PubMed ID: 23254959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.
    Winchester DA; Till C; Goodman PJ; Tangen CM; Santella RM; Johnson-Pais TL; Leach RJ; Xu J; Zheng SL; Thompson IM; Lucia MS; Lippmann SM; Parnes HL; Dluzniewski PJ; Isaacs WB; De Marzo AM; Drake CG; Platz EA
    Prostate; 2015 Sep; 75(13):1403-18. PubMed ID: 26047319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer.
    Wang V; Geybels MS; Jordahl KM; Gerke T; Hamid A; Penney KL; Markt SC; Freedman M; Pomerantz M; Lee GM; Rana H; Börnigen D; Rebbeck TR; Huttenhower C; Eeles RA; Stanford JL; Consortium P; Berndt SI; Claessens F; Sørensen KD; Park JY; Vega A; Usmani N; Mucci L; Sweeney CJ
    Prostate; 2021 Jul; 81(10):683-693. PubMed ID: 33956343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Common genetic variation of the calcium-sensing receptor and lethal prostate cancer risk.
    Shui IM; Mucci LA; Wilson KM; Kraft P; Penney KL; Stampfer MJ; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):118-26. PubMed ID: 23125333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemia.
    Suk Danik J; Chasman DI; Cannon CP; Miller DT; Zee RY; Kozlowski P; Kwiatkowski DJ; Ridker PM
    Ann Hum Genet; 2006 Nov; 70(Pt 6):705-16. PubMed ID: 17044845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Common haplotypes of the C-reactive protein gene and circulating leptin levels influence the interindividual variability in serum C-reactive protein levels. The Segovia study.
    Martínez-Calatrava MJ; González-Sánchez JL; Martínez-Larrad MT; Pérez-Barba M; Serrano-Ríos M
    Thromb Haemost; 2007 Nov; 98(5):1088-95. PubMed ID: 18000615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma antioxidants, genetic variation in SOD2, CAT, GPX1, GPX4, and prostate cancer survival.
    Van Blarigan EL; Ma J; Kenfield SA; Stampfer MJ; Sesso HD; Giovannucci EL; Witte JS; Erdman JW; Chan JM; Penney KL
    Cancer Epidemiol Biomarkers Prev; 2014 Jun; 23(6):1037-46. PubMed ID: 24711484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-Reactive protein gene variants are associated with postoperative C-reactive protein levels after coronary artery bypass surgery.
    Perry TE; Muehlschlegel JD; Liu KY; Fox AA; Collard CD; Body SC; Shernan SK;
    BMC Med Genet; 2009 May; 10():38. PubMed ID: 19426506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic polymorphism of the C-reactive protein (CRP) gene and a deep infection focus determine maximal serum CRP level in Staphylococcus aureus bacteremia.
    Mölkänen T; Rostila A; Ruotsalainen E; Alanne M; Perola M; Järvinen A
    Eur J Clin Microbiol Infect Dis; 2010 Sep; 29(9):1131-7. PubMed ID: 20552244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymorphism in the C-reactive protein (CRP) gene affects CRP levels in plasma and one early marker of atherosclerosis in men: The Health 2000 Survey.
    Kettunen T; Eklund C; Kähönen M; Jula A; Päivä H; Lyytikäinen LP; Hurme M; Lehtimäki T
    Scand J Clin Lab Invest; 2011 Sep; 71(5):353-61. PubMed ID: 21413847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-Reactive Protein Gene Variants and Their Serum Levels in Early Adult-onset Type 2 Diabetes Mellitus.
    Huang YC; Chen CC; Wang TY; Nguyen HTT; Chen YH; Wu CM; Chang YW; Liao WL; Tsai FJ
    In Vivo; 2019; 33(5):1685-1690. PubMed ID: 31471424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphism of the C-reactive protein (CRP) gene is related to serum CRP Level and arterial pulse wave velocity in healthy elderly Japanese.
    Morita A; Nakayama T; Doba N; Hinohara S; Soma M
    Hypertens Res; 2006 May; 29(5):323-31. PubMed ID: 16832152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of C-reactive protein gene polymorphisms and colorectal cancer.
    Yang SH; Huang CJ; Chang SC; Lin JK
    Ann Surg Oncol; 2011 Jul; 18(7):1907-15. PubMed ID: 21293934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive analysis of CRP, CFH Y402H and environmental risk factors on risk of neovascular age-related macular degeneration.
    Kim IK; Ji F; Morrison MA; Adams S; Zhang Q; Lane AM; Capone A; Dryja TP; Ott J; Miller JW; DeAngelis MM
    Mol Vis; 2008 Aug; 14():1487-95. PubMed ID: 18704199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older.
    Pierce BL; Biggs ML; DeCambre M; Reiner AP; Li C; Fitzpatrick A; Carlson CS; Stanford JL; Austin MA
    Cancer Causes Control; 2009 Sep; 20(7):1193-203. PubMed ID: 19267250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
    Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
    J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C-reactive protein and risk of lung cancer.
    Chaturvedi AK; Caporaso NE; Katki HA; Wong HL; Chatterjee N; Pine SR; Chanock SJ; Goedert JJ; Engels EA
    J Clin Oncol; 2010 Jun; 28(16):2719-26. PubMed ID: 20421535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between polymorphisms in the CRP, LEP and LEPR genes and high sensitivity C-reactive protein levels in Spanish children.
    Navarro P; de Dios O; Gavela-Pérez T; Soriano-Guillen L; Garcés C
    Clin Chem Lab Med; 2017 Oct; 55(11):1690-1695. PubMed ID: 28350535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.